Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

1.

Serum BMP-2 up-regulation as an indicator of poor survival in advanced non-small cell lung cancer patients.

Fei ZH, Yao CY, Yang XL, Huang XE, Ma SL.

Asian Pac J Cancer Prev. 2013;14(9):5293-9.

PMID:
24175816
[PubMed - indexed for MEDLINE]
Free Article
2.

The serum bone morphogenetic protein-2 level in non-small-cell lung cancer patients.

Choi YJ, Kim ST, Park KH, Oh SC, Seo JH, Shin SW, Kim JS, Kim YH.

Med Oncol. 2012 Jun;29(2):582-8. doi: 10.1007/s12032-011-9852-9. Epub 2011 Feb 16.

PMID:
21327739
[PubMed - indexed for MEDLINE]
3.

Circulating serum vascular endothelial growth factor is not a prognostic factor of non-small cell lung cancer.

Chakra M, Pujol JL, Lamy PJ, Bozonnat MC, Quantin X, Jacot W, Daurès JP.

J Thorac Oncol. 2008 Oct;3(10):1119-26. doi: 10.1097/JTO.0b013e318187464e.

PMID:
18827607
[PubMed - indexed for MEDLINE]
4.

VEGF and TSP1 levels correlate with prognosis in advanced non-small cell lung cancer.

Fleitas T, Martínez-Sales V, Vila V, Reganon E, Mesado D, Martín M, Gómez-Codina J, Montalar J, Reynés G.

Clin Transl Oncol. 2013 Nov;15(11):897-902. doi: 10.1007/s12094-013-1020-6. Epub 2013 Mar 5.

PMID:
23463593
[PubMed - indexed for MEDLINE]
5.

Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.

Oven Ustaalioglu B, Bilici A, Ercan S, Orcun A, Seker M, Ozkan A, Ustaalioglu R, Gumus M.

Clin Transl Oncol. 2012 May;14(5):356-61. doi: 10.1007/s12094-012-0808-0.

PMID:
22551541
[PubMed - indexed for MEDLINE]
6.

Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.

Ylisirniö S, Höyhtyä M, Turpeenniemi-Hujanen T.

Anticancer Res. 2000 Mar-Apr;20(2B):1311-6.

PMID:
10810441
[PubMed - indexed for MEDLINE]
7.

The value of serum Bcl-2 levels in advanced lung cancer patients.

Tas F, Duranyildiz D, Oguz H, Camlica H, Oral EN, Yasasever V, Topuz E.

Med Oncol. 2005;22(2):139-43.

PMID:
15965276
[PubMed - indexed for MEDLINE]
8.

Circulating interleukin-6 level is a prognostic marker for survival in advanced nonsmall cell lung cancer patients treated with chemotherapy.

Chang CH, Hsiao CF, Yeh YM, Chang GC, Tsai YH, Chen YM, Huang MS, Chen HL, Li YJ, Yang PC, Chen CJ, Hsiung CA, Su WC.

Int J Cancer. 2013 May 1;132(9):1977-85. doi: 10.1002/ijc.27892. Epub 2012 Oct 29.

PMID:
23034889
[PubMed - indexed for MEDLINE]
9.

Serum IL-33 as a diagnostic and prognostic marker in non- small cell lung cancer.

Hu LA, Fu Y, Zhang DN, Zhang J.

Asian Pac J Cancer Prev. 2013;14(4):2563-6.

PMID:
23725175
[PubMed - indexed for MEDLINE]
Free Article
10.

Behaviour of interleukin-2 serum levels in advanced non-small-cell lung cancer patients: relationship with response to therapy and survival.

Orditura M, Romano C, De Vita F, Galizia G, Lieto E, Infusino S, De Cataldis G, Catalano G.

Cancer Immunol Immunother. 2000 Dec;49(10):530-6.

PMID:
11129323
[PubMed - indexed for MEDLINE]
11.

Prognostic significance of metastasis to the highest mediastinal lymph node in nonsmall cell lung cancer.

Sakao Y, Miyamoto H, Yamazaki A, Oh T, Fukai R, Shiomi K, Saito Y.

Ann Thorac Surg. 2006 Jan;81(1):292-7.

PMID:
16368383
[PubMed - indexed for MEDLINE]
12.

Prognostic role of serum cytokeratin 19 fragments in advanced non-small-cell lung cancer: association of marker changes after two chemotherapy cycles with different measures of clinical response and survival.

Nisman B, Biran H, Heching N, Barak V, Ramu N, Nemirovsky I, Peretz T.

Br J Cancer. 2008 Jan 15;98(1):77-9. Epub 2007 Dec 18.

PMID:
18087272
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease.

Okada M, Nishio W, Sakamoto T, Uchino K, Yuki T, Nakagawa A, Tsubota N.

Ann Thorac Surg. 2004 Jul;78(1):216-21.

PMID:
15223432
[PubMed - indexed for MEDLINE]
14.

Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer.

Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, Mandai K, Eguchi K.

Anticancer Res. 2000 May-Jun;20(3B):2177-80.

PMID:
10928173
[PubMed - indexed for MEDLINE]
15.

Vascular endothelial growth factor in the serum of patients with non-small cell lung cancer: correlation with platelet and leukocyte counts.

Choi JH, Kim HC, Lim HY, Nam DK, Kim HS, Yi JW, Chun M, Oh YT, Kang S, Park KJ, Hwang SC, Lee YH, Hahn MH.

Lung Cancer. 2001 Aug-Sep;33(2-3):171-9.

PMID:
11551412
[PubMed - indexed for MEDLINE]
16.

The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.

Milman N, Pedersen LM.

Oncol Rep. 2002 Jan-Feb;9(1):193-8.

PMID:
11748482
[PubMed - indexed for MEDLINE]
17.

Differential expression of ERCC-1 in the primary tumors and metastatic lymph nodes of patients with non-small cell lung cancer adenocarcinoma.

Zhang W, Guo N, Yu C, Wang H, Zhang Y, Xia H, Yu J, Lu J.

Tumour Biol. 2012 Dec;33(6):2209-16. doi: 10.1007/s13277-012-0482-4. Epub 2012 Aug 14.

PMID:
22890830
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Serum CYFRA 21-1 in advanced stage non-small cell lung cancer: an early measure of response.

Vollmer RT, Govindan R, Graziano SL, Gamble G, Garst J, Kelley MJ, Christenson RH.

Clin Cancer Res. 2003 May;9(5):1728-33.

PMID:
12738727
[PubMed - indexed for MEDLINE]
Free Article
19.

Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.

Li H, Tang K, Niu L, Liang Y, Li J, Chen J, Xu K.

Cancer Biomark. 2013;13(5):337-43. doi: 10.3233/CBM-130368.

PMID:
24440973
[PubMed - indexed for MEDLINE]
20.

Serum vascular endothelial growth factor and COX-2/5-LOX inhibition in advanced non-small cell lung cancer: Cancer and Leukemia Group B 150304.

Edelman MJ, Hodgson L, Wang X, Christenson R, Jewell S, Vokes E, Kratzke R.

J Thorac Oncol. 2011 Nov;6(11):1902-6. doi: 10.1097/JTO.0b013e31822a7383.

PMID:
21964530
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk